Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system

The importance of neovascularization and its inhibition for allogeneic hematopoietic stem cell transplantation

(2011) O. Penack et al.   BLOOD

Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis*

(2011) Daniel R. Ricciuto et al.   CRITICAL CARE MEDICINE

Graft-versus-Host Disease Treatment: Predictors of Survival

(2010) John E. Levine et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Pentostatin for treatment of steroid-refractory acute GVHD: a retrospective single-center analysis

(2010) T Schmitt et al.   BONE MARROW TRANSPLANTATION

The role of the Angiopoietins in vascular morphogenesis

(2009) Markus Thomas et al.   ANGIOGENESIS

The Release of Soluble Factors Contributing to Endothelial Activation and Damage after Hematopoietic Stem Cell Transplantation Is Not Limited to the Allogeneic Setting and Involves Several Pathogenic Mechanisms

(2009) Marta Palomo et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network

(2009) A. M. Alousi et al.   BLOOD

Risk score for outcome after allogeneic hematopoietic stem cell transplantation

(2009) Alois Gratwohl et al.   CANCER

Graft-versus-host disease

(2009) James LM Ferrara et al.   LANCET

The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus

(2008) P Kumpers et al.   ANNALS OF THE RHEUMATIC DISEASES

Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors

(2008) M. L. MacMillan et al.   BLOOD